Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Proofpoint Expects Pricing IPO In $10-$12/Shr Range - Quick Facts

RELATED NEWS
Trade PFPT now with 

Proofpoint, Inc. said it estimates pricing the initial public offering of its common stock in a range between $10.00 and $12.00 per share.

The company is selling 5 million shares of common stock and the selling stockholders identified in this prospectus are selling 1.199 million shares of common stock. Proofpoint said it will not receive any of the proceeds from the sale of shares of common stock by the selling stockholders.

Prior to this offering, there has been no public market for the company's common stock. Proofpoint has applied to list its common stock on the NASDAQ Global Market under the symbol "PFPT."

The underwriters have the option to purchase from the company a maximum of 750 thousand additional shares and from the selling stockholders a maximum of 179,914 additional shares to cover over-allotments of shares.

Click here to receive FREE breaking news email alerts for Proofpoint, Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Here is a list of interesting stocks to watch on December 19. The good news is you can skip this step. There is a next move that can make your life a lot easier. Our research team has already done the groundwork for you. All these stocks listed below and many more have been researched already, and... Shares of OvaScience Inc. (OVAS) have had a strong run in 2014, rising over 370 percent year-to-date. And that's indeed a very impressive return delivered by the fertility treatment company, which suffered a setback last year when it had to suspend a U.S. trial of its flagship fertility treatment due to regulatory concerns raised by the FDA. Nike Inc., the world's largest athletic shoes and apparel maker, said Thursday after the markets closed that its second quarter profit rose 23% from last year, helped by higher revenue and improved gross margin. The company's quarterly earnings per share also came in above analysts' expectations as did its quarterly revenue.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.